Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 18;11(1):56.
doi: 10.1038/s41398-020-01082-z.

Synaptic processes and immune-related pathways implicated in Tourette syndrome

Fotis Tsetsos  1 Dongmei Yu  2   3 Jae Hoon Sul  4   5 Alden Y Huang  4   5   6 Cornelia Illmann  2 Lisa Osiecki  2 Sabrina M Darrow  7 Matthew E Hirschtritt  7 Erica Greenberg  8 Kirsten R Muller-Vahl  9 Manfred Stuhrmann  10 Yves Dion  11 Guy A Rouleau  12 Harald Aschauer  13   14 Mara Stamenkovic  13 Monika Schlögelhofer  14 Paul Sandor  15 Cathy L Barr  16 Marco A Grados  17 Harvey S Singer  17 Markus M Nöthen  18 Johannes Hebebrand  19 Anke Hinney  19 Robert A King  20 Thomas V Fernandez  20 Csaba Barta  21 Zsanett Tarnok  22 Peter Nagy  22 Christel Depienne  23   24 Yulia Worbe  24   25   26   27 Andreas Hartmann  24   25   26 Cathy L Budman  28 Renata Rizzo  29 Gholson J Lyon  30 William M McMahon  31 James R Batterson  32 Danielle C Cath  33 Irene A Malaty  34 Michael S Okun  34 Cheston Berlin  35 Douglas W Woods  36 Paul C Lee  37 Joseph Jankovic  38 Mary M Robertson  39 Donald L Gilbert  40 Lawrence W Brown  41 Barbara J Coffey  42 Andrea Dietrich  43 Pieter J Hoekstra  43 Samuel Kuperman  44 Samuel H Zinner  45 Michael Wagner  46 James A Knowles  47 A Jeremy Willsey  48 Jay A Tischfield  49 Gary A Heiman  49 Nancy J Cox  50 Nelson B Freimer  4   5 Benjamin M Neale  2   3   51 Lea K Davis  50 Giovanni Coppola  4   5 Carol A Mathews  52 Jeremiah M Scharf  2   3   53 Peristera Paschou  54 Tourette Association of America International Consortium for GeneticsCathy L Barr  16 James R Batterson  32 Cheston Berlin  35 Cathy L Budman  28 Danielle C Cath  33 Giovanni Coppola  4   5 Nancy J Cox  50 Sabrina Darrow  7 Lea K Davis  50 Yves Dion  11 Nelson B Freimer  4   5 Marco A Grados  17 Erica Greenberg  8 Matthew E Hirschtritt  7 Alden Y Huang  4   5   6 Cornelia Illmann  2 Robert A King  20 Roger Kurlan  55 James F Leckman  56 Gholson J Lyon  30 Irene A Malaty  34 Carol A Mathews  52 William M McMahon  31 Benjamin M Neale  2   3   51 Michael S Okun  34 Lisa Osiecki  2 Mary M Robertson  39 Guy A Rouleau  12 Paul Sandor  15 Jeremiah M Scharf  2   3   53 Harvey S Singer  17 Jan H Smit  57 Jae Hoon Sul  4   5 Dongmei Yu  2   3 Gilles de la Tourette GWAS Replication InitiativeHarald Aschauer Harald Aschauer  13   14 Csaba Barta  21 Cathy L Budman  28 Danielle C Cath  33 Christel Depienne  23   24 Andreas Hartmann  24   25   26 Johannes Hebebrand  19 Anastasios Konstantinidis  13   58 Carol A Mathews  52 Kirsten Müller-Vahl  9 Peter Nagy  22 Markus M Nöthen  18 Peristera Paschou  59 Renata Rizzo  29 Guy A Rouleau  12 Paul Sandor  15 Jeremiah M Scharf  2   3   53 Monika Schlögelhofer  14 Mara Stamenkovic  13 Manfred Stuhrmann  10 Fotis Tsetsos  1 Zsanett Tarnok  22 Tomasz Wolanczyk  60 Yulia Worbe  24   25   26   27 Tourette International Collaborative Genetics StudyLawrence Brown  41 Keun-Ah Cheon  61 Barbara J Coffey  42 Andrea Dietrich  43 Thomas V Fernandez  20 Blanca Garcia-Delgar  62 Donald Gilbert  40 Dorothy E Grice  63 Julie Hagstrøm  64 Tammy Hedderly  65   66 Gary A Heiman  49 Isobel Heyman  67   68 Pieter J Hoekstra  43 Chaim Huyser  69 Young Key Kim  70 Young-Shin Kim  71 Robert A King  20 Yun-Joo Koh  72 Sodahm Kook  73 Samuel Kuperman  44 Bennett L Leventhal  71 Marcos Madruga-Garrido  74 Pablo Mir  75   76 Astrid Morer  77   78   79 Alexander Münchau  80 Kerstin J Plessen  81   82   83 Veit Roessner  84 Eun-Young Shin  61 Dong-Ho Song  61 Jungeun Song  85 Jay A Tischfield  49 A Jeremy Willsey  48 Samuel Zinner  45 Psychiatric Genomics Consortium Tourette Syndrome Working GroupHarald Aschauer  13   14 Cathy L Barr  16 Csaba Barta  21 James R Batterson  32 Cheston Berlin  35 Lawrence Brown  41 Cathy L Budman  28 Danielle C Cath  33 Barbara J Coffey  42 Giovanni Coppola  4   5 Nancy J Cox  50 Sabrina Darrow  7 Lea K Davis  50 Christel Depienne  23   24 Andrea Dietrich  43 Yves Dion  11 Thomas Fernandez  20 Nelson B Freimer  4   5 Donald Gilbert  40 Marco A Grados  17 Erica Greenberg  8 Andreas Hartmann  24   25   26 Johannes Hebebrand  19 Gary Heiman  49 Matthew E Hirschtritt  7 Pieter Hoekstra  43 Alden Y Huang  4   5   6 Cornelia Illmann  2 Joseph Jankovic  38 Robert A King  20 Samuel Kuperman  44 Paul C Lee  37 Gholson J Lyon  30 Irene A Malaty  34 Carol A Mathews  52 William M McMahon  31 Kirsten Müller-Vahl  9 Peter Nagy  22 Benjamin M Neale  2   3   51 Markus M Nöthen  18 Michael S Okun  34 Lisa Osiecki  2 Peristera Paschou  59 Renata Rizzo  29 Mary M Robertson  39 Guy A Rouleau  12 Paul Sandor  15 Jeremiah M Scharf  2   3   53 Monika Schlögelhofer  14 Harvey S Singer  17 Mara Stamenkovic  13 Manfred Stuhrmann  10 Jae Hoon Sul  4   5 Zsanett Tarnok  22 Jay Tischfield  49 Fotis Tsetsos  1 A Jeremy Willsey  48 Douglas Woods  36 Yulia Worbe  24   25   26   27 Dongmei Yu  2   3 Samuel Zinner  45
Affiliations

Synaptic processes and immune-related pathways implicated in Tourette syndrome

Fotis Tsetsos et al. Transl Psychiatry. .

Abstract

Tourette syndrome (TS) is a neuropsychiatric disorder of complex genetic architecture involving multiple interacting genes. Here, we sought to elucidate the pathways that underlie the neurobiology of the disorder through genome-wide analysis. We analyzed genome-wide genotypic data of 3581 individuals with TS and 7682 ancestry-matched controls and investigated associations of TS with sets of genes that are expressed in particular cell types and operate in specific neuronal and glial functions. We employed a self-contained, set-based association method (SBA) as well as a competitive gene set method (MAGMA) using individual-level genotype data to perform a comprehensive investigation of the biological background of TS. Our SBA analysis identified three significant gene sets after Bonferroni correction, implicating ligand-gated ion channel signaling, lymphocytic, and cell adhesion and transsynaptic signaling processes. MAGMA analysis further supported the involvement of the cell adhesion and trans-synaptic signaling gene set. The lymphocytic gene set was driven by variants in FLT3, raising an intriguing hypothesis for the involvement of a neuroinflammatory element in TS pathogenesis. The indications of involvement of ligand-gated ion channel signaling reinforce the role of GABA in TS, while the association of cell adhesion and trans-synaptic signaling gene set provides additional support for the role of adhesion molecules in neuropsychiatric disorders. This study reinforces previous findings but also provides new insights into the neurobiology of TS.

PubMed Disclaimer

Conflict of interest statement

I.M. has participated in research funded by the Parkinson Foundation, Tourette Association, Dystonia Coalition, AbbVie, Biogen, Boston Scientific, Eli Lilly, Impax, Neuroderm, Prilenia, Revance, Teva but has no owner interest in any pharmaceutical company. She has received travel compensation or honoraria from the Tourette Association of America, Parkinson Foundation, International Association of Parkinsonism and Related Disorders, Medscape, and Cleveland Clinic, and royalties for writing a book with Robert rose publishers. K.M.V. has received financial or material research support from the EU (FP7-HEALTH-2011 No. 278367, FP7-PEOPLE-2012-ITN No. 316978), the German Research Foundation (DFG: GZ MU 1527/3-1), the German Ministry of Education and Research (BMBF: 01KG1421), the National Institute of Mental Health (NIMH), the Tourette Gesellschaft Deutschland e.V., the Else-Kroner-Fresenius-Stiftung, and GW, Almirall, Abide Therapeutics, and Therapix Biosiences and has received consultant’s honoraria from Abide Therapeutics, Tilray, Resalo Vertrieb GmbH, and Wayland Group, speaker’s fees from Tilray and Cogitando GmbH, and royalties from Medizinisch Wissenschaftliche Verlagsgesellschaft Berlin, Elsevier, and Kohlhammer; and is a consultant for Nuvelution TS Pharma Inc., Zynerba Pharmaceuticals, Resalo Vertrieb GmbH, CannaXan GmbH, Therapix Biosiences, Syqe, Nomovo Pharma, and Columbia Care. B.M.N. is a member of the scientific advisory board at Deep Genomics and consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. M.M.N. has received fees for memberships in Scientific Advisory Boards from the Lundbeck Foundation and the Robert-Bosch-Stiftung, and for membership in the Medical-Scientific Editorial Office of the Deutsches Ärzteblatt. M.M.N. was reimbursed travel expenses for a conference participation by Shire Deutschland GmbH. M.M.N. receives salary payments from Life & Brain GmbH and holds shares in Life & Brain GmbH. All this concerned activities outside the submitted work. M.S.O. serves as a consultant for the Parkinson’s Foundation, and has received research grants from NIH, Parkinson’s Foundation, the Michael J. Fox Foundation, the Parkinson Alliance, Smallwood Foundation, the Bachmann-Strauss Foundation, the Tourette Syndrome Association, and the UF Foundation. M.S.O.’s DBS research is supported by NIH R01 NR014852 and R01NS096008. M.S.O. is PI of the NIH R25NS108939 Training Grant. M.S.O. has received royalties for publications with Demos, Manson, Amazon, Smashwords, Books4Patients, Perseus, Robert Rose, Oxford and Cambridge (movement disorders books). M.S.O. is an associate editor for New England Journal of Medicine Journal Watch Neurology. M.S.O. has participated in CME and educational activities on movement disorders sponsored by the Academy for Healthcare Learning, PeerView, Prime, QuantiaMD, WebMD/Medscape, Medicus, MedNet, Einstein, MedNet, Henry Stewart, American Academy of Neurology, Movement Disorders Society, and by Vanderbilt University. The institution and not M.S.O. receives grants from Medtronic, Abbvie, Boston Scientific, Abbott and Allergan and the PI has no financial interest in these grants. M.S.O. has participated as a site PI and/or co-I for several NIH, foundation, and industry sponsored trials over the years but has not received honoraria. Research projects at the University of Florida receive device and drug donations. D.W. receives royalties for books on Tourette Syndrome with Guilford Press, Oxford University Press, and Springer Press. The rest of the authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Results of gene set analysis as implemented by MAGMA.
The gene set that crossed the significance threshold is depicted in red.
Fig. 2
Fig. 2. Results of gene set analysis as implemented by SBA.
The gene sets that crossed the significance threshold are depicted in red.

References

    1. Robertson MM, Cavanna AE, Eapen V. Gilles de la Tourette syndrome and disruptive behavior disorders: prevalence, associations, and explanation of the relationships. J. Neuropsychiatry Clin. Neurosci. 2015;27:33–41. doi: 10.1176/appi.neuropsych.13050112. - DOI - PubMed
    1. Scharf JM, et al. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov. Disord. 2015;30:221–228. doi: 10.1002/mds.26089. - DOI - PubMed
    1. Robertson MM, Eapen V, Cavanna AE. he international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective. J. Psychosom. Res. 2009;67:475–483. doi: 10.1016/j.jpsychores.2009.07.010. - DOI - PubMed
    1. Davis, L. K. Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genetics9, e1003864 (2013). - PMC - PubMed
    1. Robertson MM. Gilles de la Tourette syndrome. Nat. Rev. Dis. Prim. 2017;3:16097. doi: 10.1038/nrdp.2016.97. - DOI - PubMed

Publication types